Sector portfolio · VC firm · France

KurmaPartners' Biotech portfolio

KurmaPartners has backed 31 Biotech startups in rounds we track, $1.8B between them, shown by the stage each has reached. The best-funded is Alveus Therapeutics Inc..

31startups backed
4stages
$1.8Braised between them
Series Abiggest stage

KurmaPartners's whole portfolioKurmaPartners's profile

Series A

11

Series B

8

Pre-seed and seed

6

Series C and later

6

Segment by segment

Series A

11 startups · $810M raised

  1. Alveus Therapeutics Inc.Alveus Therapeutics Inc is a clinical-stage biotechnology company focused on developing innovative therapies for obesity and metabUnited States$197M
  2. AdcytherixAdcytherix is a clinical-stage biopharmaceutical company based in Marseille, France.France$122M
  3. Vivet TherapeuticsVivet Therapeutics is a biotechnology company developing gene therapy treatments for orphan diseases.France$96M
  4. APAlizé Pharma 3France$74M
  5. Corteria PharmaceuticalsCorteria Pharmaceuticals is a clinical-stage biopharmaceutical company based in Paris, France, founded in 2021.France$70M
  6. SciRhomSciRhom GmbH is a biotechnology company based in Martinsried, Germany, founded in 2016.Germany$68M
  7. AARGOBIOCMP therapeutics develops immunomodulators for allergy, and infectious diseases.United Kingdom$60M
  8. Minoryx TherapeuticsMinoryx Therapeutics offers pharmacological chaperones, which are small molecule drugs used for the treatment of genetic diseases.Spain$57M

Series B

8 startups · $403M raised

  1. PharvarisPharvaris is a clinical-stage biomedical company focused on bringing oral bradykinin B2-receptor antagonists to patients.Switzerland$132M
  2. ImCheck TherapeuticsImCheck Therapeutics is a developing novel therapeutics that target members of the butyrophilin (BTN) super-family of checkpoint molecules.France$97M
  3. DNA ScriptDNA Script is a disruptive DNA synthesis company harnessing biology to accelerate breakthroughs in life science and human health.France$62M
  4. Shorla PharmaShorla Pharma is an Irish specialty pharmaceutical company.Ireland$35M
  5. MMinoryxSpain$25M
  6. PathoQuestPathoQuest is a biotech company developing NGS-based metagenomic tests for exhaustive identification of pathogens.France$22M
  7. DAMAE MedicalDamae Medical is a French medtech company founded in 2014, focused on improving skin cancer diagnosis through innovative imaging technology.France$17M
  8. Vico TherapeuticsVico Therapeutics is a clinical-stage genetic medicines company based in Leiden, the Netherlands.Netherlands$12M

Pre-seed and seed

6 startups · $100M raised

  1. TacalyxTacalyx is a biotech company focused on the discovery and development of novel anti-TACAGermany$28M
  2. EvlaBioEvlaBio AG is a life science startup based in Zürich, Switzerland, founded in 2022.Switzerland$25M
  3. Laigo BioLaigo Bio is a biotech company based in Utrecht, Netherlands, founded in 2021.Netherlands$20M
  4. ElkedoniaElkedonia is a biotech startup founded in 2025 by Argobio, based in Strasbourg, France, with an affiliate in Charleroi, Belgium.France$13M
  5. AxithraAxithra is a Belgian health technology company founded in 2023, emerging from the Photonics Research Group at Ghent University and imec.Belgium$11M
  6. Brink TherapeuticsBrink Therapeutics is a seed-stage TechBio company based in Paris, France, founded in 2024.France$4.0M

Series C and later

6 startups · $453M raised

  1. AM PharmaAM-Pharma is a Dutch clinical-stage biopharmaceutical company founded in 2001 and based in Utrecht, Netherlands.Netherlands$189M
  2. DynacureDynacure is a clinical-stage drug development company focused on improving the lives of patients with rare and orphan diseases.France$109M
  3. DeepUlldeepull is a Barcelona-based clinical diagnostics company founded in 2020.Spain$57M
  4. Stilla TechnologiesStilla Technologies is a Paris-based european biotechnology company.France$45M
  5. STAT-DxSTAT-Dx is focused on the development of near-patient testing products for healthcare professionals.-$29M
  6. Memo TherapeuticsMemo Therapeutics is an innovator in the field of antibody discovery and immune repertoire analysis.Switzerland$24M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names KurmaPartners as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Portfolio mapKurmaPartners portfolio map46 startups · $2.6BCo-investorsWho invests with KurmaPartners25 co-investorsSector portfolioKima Ventures' AI portfolio79 startups · $975MSector portfolioSofinnova Partners' Biotech portfolio66 startups · $5.9BSector portfolioKima Ventures' IT Services portfolio55 startups · $233MSector portfolioKima Ventures' Fintech portfolio42 startups · $2.6B

Raising from investors like KurmaPartners?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps